CS-PHH3 Algorithm by NucleIQ® for

Tumors

Automation and Quantification in Mitosis Evaluation

Identifies and quantifies cells in the mitotic phase in malignant tumors using Phosphohistone 3 (PHH3) and hematoxylin-eosin (H&E) staining

Improved Precision and Efficiency

It accelerates the diagnostic process, ensuring accurate identification of cells in the mitotic phase.

Variability Reduction

It minimizes manual intervention, providing consistent and reproducible results.

Standardization in Tumor Analysis

It offers a uniform and objective interpretation, crucial for accurate diagnosis and treatment monitoring.
Access to the website

The information on this website is intended exclusively for healthcare professionals; this content is not intended for the general public.